Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to -$29000.0.

  • iBio's Change in Account Payables rose 8796.68% to -$29000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 million, marking a year-over-year increase of 26380.42%. This contributed to the annual value of $1.8 million for FY2025, which is 22280.35% up from last year.
  • Latest data reveals that iBio reported Change in Account Payables of -$29000.0 as of Q4 2025, which was up 8796.68% from $495000.0 recorded in Q3 2025.
  • In the past 5 years, iBio's Change in Account Payables ranged from a high of $1.0 million in Q4 2022 and a low of -$1.7 million during Q1 2023
  • Its 5-year average for Change in Account Payables is $48850.0, with a median of $70500.0 in 2021.
  • Over the last 5 years, iBio's Change in Account Payables had its largest YoY gain of 75833.33% in 2021, and its largest YoY loss of 82844.04% in 2021.
  • iBio's Change in Account Payables (Quarter) stood at $793000.0 in 2021, then rose by 27.62% to $1.0 million in 2022, then tumbled by 105.04% to -$51000.0 in 2023, then tumbled by 372.55% to -$241000.0 in 2024, then surged by 87.97% to -$29000.0 in 2025.
  • Its Change in Account Payables stands at -$29000.0 for Q4 2025, versus $495000.0 for Q3 2025 and $712000.0 for Q2 2025.